Gall Matthew - Insider Non-Derivative Transactions at iTeos Therapeutics, Inc. (ITOS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 5, 2023, Gall Matthew's relationship to iTeos Therapeutics, Inc. (ITOS) is Officer (Chief Financial Officer), and currently has 60,429 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ITOS insiders.
Data Source: SEC.
Gall Matthew - Insider Non-Derivative Transactions of ITOS Common Stock
Gall Matthew - Insider Non-Derivative Transactions at ITOS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 6, 2023 | Acquisition -- (Common Stock) | 41000 | 0 | 60429 |
| Oct 13, 2023 | P -- (Common Stock) | 5000 | 8.37 | 19429 |